Patent system central to a Sars vaccine
Research is underway into patenting treatments for the Sars virus. But patent systems are not the same everywhere, especially where living organisms are concerned. Researchers need to be aware of the differences, warns Aaradhana Sadasivam
Reports that Severe Acute Respiratory Syndrome (Sars) may make a
comeback later this year have proven to be true. It has only been a
few months since Singapore and other countries in the region were
declared Sars-free. The strict precautions and safeguards which
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.